trial · primary record
Nerandomilast
Familial Pulmonary Fibrosis
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 80 |
| Primary completion | 2029-05-23 |
| Primary endpoint | Time to physiologic or radiologic worsening of ILA/ILD over the whole trial |
| Registry ID | NCT07201922 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:33.909Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07201922
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- NERANDOMILAST · approval
- NERANDOMILAST · approval
- Nerandomilast · compound